| Dr Joel W Mcmasters, MD | |
|
4301 W Markham St # 515, Little Rock, AR 72205-7101 | |
| (501) 686-6114 | |
| (501) 686-8139 |
| Full Name | Dr Joel W Mcmasters |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 26 Years |
| Location | 4301 W Markham St # 515, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326039876 | NPI | - | NPPES |
| 182593001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | E-5334 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uams Medical Center | Little rock, AR | Hospital |
| Baptist Health Medical Center-little Rock | Little rock, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Arkansas | 4082528955 | 1121 |
| Arkansas Health Group | 7911802079 | 541 |
News Archive
Labopharm Inc. today announced that on November 11, 2010 it received notice from Actavis South Atlantic LLC advising that Actavis has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 150 and 300 mg generic versions of OLEPTRO™ (trazodone hydrochloride extended-release 150 and 300 mg tablets) in the United States.
Previous research on an apparent narrowing of the historical "gender gap" in drinking prevalence found that girls were more likely to start drinking before 18 years of age compared to boys.
Scientists thought they basically knew how the most common drugs used to treat type 2 diabetes worked, but a new study from the Florida campus of The Scripps Research Institute (TSRI) reveals unexpected new aspects of the process. These findings could eventually lead to more potent anti-diabetic drugs with fewer serious side effects.
New research provides insight into a long-observed, but little-understood connection between chronic pain and anxiety and offers a potential target for treatment.
Because of 1988 and 1990 amendments to the Food, Drug and Cosmetic Act, off-label distribution or provision of human growth hormone to treat aging or age-associated illnesses is illegal in the United States, according to a report in the Journal of the American Medical Association.
› Verified 7 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588654016 PECOS PAC ID: 4082528955 Enrollment ID: O20031219000706 |
News Archive
Labopharm Inc. today announced that on November 11, 2010 it received notice from Actavis South Atlantic LLC advising that Actavis has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 150 and 300 mg generic versions of OLEPTRO™ (trazodone hydrochloride extended-release 150 and 300 mg tablets) in the United States.
Previous research on an apparent narrowing of the historical "gender gap" in drinking prevalence found that girls were more likely to start drinking before 18 years of age compared to boys.
Scientists thought they basically knew how the most common drugs used to treat type 2 diabetes worked, but a new study from the Florida campus of The Scripps Research Institute (TSRI) reveals unexpected new aspects of the process. These findings could eventually lead to more potent anti-diabetic drugs with fewer serious side effects.
New research provides insight into a long-observed, but little-understood connection between chronic pain and anxiety and offers a potential target for treatment.
Because of 1988 and 1990 amendments to the Food, Drug and Cosmetic Act, off-label distribution or provision of human growth hormone to treat aging or age-associated illnesses is illegal in the United States, according to a report in the Journal of the American Medical Association.
› Verified 7 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346230968 PECOS PAC ID: 4082528955 Enrollment ID: O20040115000431 |
News Archive
Labopharm Inc. today announced that on November 11, 2010 it received notice from Actavis South Atlantic LLC advising that Actavis has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 150 and 300 mg generic versions of OLEPTRO™ (trazodone hydrochloride extended-release 150 and 300 mg tablets) in the United States.
Previous research on an apparent narrowing of the historical "gender gap" in drinking prevalence found that girls were more likely to start drinking before 18 years of age compared to boys.
Scientists thought they basically knew how the most common drugs used to treat type 2 diabetes worked, but a new study from the Florida campus of The Scripps Research Institute (TSRI) reveals unexpected new aspects of the process. These findings could eventually lead to more potent anti-diabetic drugs with fewer serious side effects.
New research provides insight into a long-observed, but little-understood connection between chronic pain and anxiety and offers a potential target for treatment.
Because of 1988 and 1990 amendments to the Food, Drug and Cosmetic Act, off-label distribution or provision of human growth hormone to treat aging or age-associated illnesses is illegal in the United States, according to a report in the Journal of the American Medical Association.
› Verified 7 days ago
| Entity Name | Arkansas Health Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508800962 PECOS PAC ID: 7911802079 Enrollment ID: O20040331000754 |
News Archive
Labopharm Inc. today announced that on November 11, 2010 it received notice from Actavis South Atlantic LLC advising that Actavis has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 150 and 300 mg generic versions of OLEPTRO™ (trazodone hydrochloride extended-release 150 and 300 mg tablets) in the United States.
Previous research on an apparent narrowing of the historical "gender gap" in drinking prevalence found that girls were more likely to start drinking before 18 years of age compared to boys.
Scientists thought they basically knew how the most common drugs used to treat type 2 diabetes worked, but a new study from the Florida campus of The Scripps Research Institute (TSRI) reveals unexpected new aspects of the process. These findings could eventually lead to more potent anti-diabetic drugs with fewer serious side effects.
New research provides insight into a long-observed, but little-understood connection between chronic pain and anxiety and offers a potential target for treatment.
Because of 1988 and 1990 amendments to the Food, Drug and Cosmetic Act, off-label distribution or provision of human growth hormone to treat aging or age-associated illnesses is illegal in the United States, according to a report in the Journal of the American Medical Association.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joel W Mcmasters, MD 4301 W Markham St # 783, Little Rock, AR 72205-7101 Ph: (501) 686-8000 | Dr Joel W Mcmasters, MD 4301 W Markham St # 515, Little Rock, AR 72205-7101 Ph: (501) 686-6114 |
News Archive
Labopharm Inc. today announced that on November 11, 2010 it received notice from Actavis South Atlantic LLC advising that Actavis has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 150 and 300 mg generic versions of OLEPTRO™ (trazodone hydrochloride extended-release 150 and 300 mg tablets) in the United States.
Previous research on an apparent narrowing of the historical "gender gap" in drinking prevalence found that girls were more likely to start drinking before 18 years of age compared to boys.
Scientists thought they basically knew how the most common drugs used to treat type 2 diabetes worked, but a new study from the Florida campus of The Scripps Research Institute (TSRI) reveals unexpected new aspects of the process. These findings could eventually lead to more potent anti-diabetic drugs with fewer serious side effects.
New research provides insight into a long-observed, but little-understood connection between chronic pain and anxiety and offers a potential target for treatment.
Because of 1988 and 1990 amendments to the Food, Drug and Cosmetic Act, off-label distribution or provision of human growth hormone to treat aging or age-associated illnesses is illegal in the United States, according to a report in the Journal of the American Medical Association.
› Verified 7 days ago
Faber A White, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1701 S Shackleford Rd, Little Rock, AR 72211 Phone: 501-219-7481 | |
Louis W Sessions, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9601 Interstate 630 Exit 7, Little Rock, AR 72205 Phone: 501-202-2093 | |
David M Dean, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9601 Interstate 630 Exit 7, Little Rock, AR 72205 Phone: 501-202-2093 | |
Ken Wade, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9601 Interstate 630 Exit 7, Little Rock, AR 72205 Phone: 501-202-2093 | |
Garry Jones, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 500 S University Ave, Suite 505, Little Rock, AR 72205 Phone: 501-664-4532 Fax: 501-663-4335 | |
Mrs. Tatiana Puntarelli, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1 Childrens Way # 203, Little Rock, AR 72202 Phone: 501-364-1100 Fax: 501-364-4082 | |
Gregory Ryan Mehaffey, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 |